Cargando…
Assessment of High Risk for Alzheimer’s Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study
BACKGROUND: In Alzheimer’s disease (AD), cognitive impairment begins 10–15 years later than neurodegeneration in the brain. Plasma biomarkers are promising candidates for assessing neurodegeneration in people with normal cognition. It has been reported that subjects with the concentration of plasma...
Autores principales: | Hu, Chaur-Jong, Chiu, Ming-Jang, Pai, Ming-Chyi, Yan, Sui-Hing, Wang, Pei-Ning, Chiu, Pai-Yi, Lin, Chin-Hsien, Chen, Ta-Fu, Yang, Fu-Chi, Huang, Kuo-Lun, Hsu, Yi-Ting, Hou, Yi-Chou, Lin, Wei-Che, Lu, Cheng-Hsien, Huang, Li-Kai, Yang, Shieh-Yueh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609520/ https://www.ncbi.nlm.nih.gov/pubmed/34870102 http://dx.doi.org/10.3233/ADR-210310 |
Ejemplares similares
-
Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects
por: Pai, Ming-Chyi, et al.
Publicado: (2022) -
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022) -
Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020) -
Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021) -
Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry–publication on behalf of Taiwan Society of Nephrology
por: Chiu, Hsien-Fu, et al.
Publicado: (2018)